Results 141 to 150 of about 11,018 (183)

Cutaneous Eyelid Neoplasms as a Toxicity of Vemurafenib Therapy [PDF]

open access: yesOphthalmic Plastic and Reconstructive Surgery, 2015
The discovery of BRAF mutation in ~50% of melanomas led to the development of small molecule BRAF inhibitors, including sorafenib, debrafenib, and vemurafenib. Clinical trials have shown these agents to be effective in treatment of metastatic and locally advanced melanoma, increasing overall and progression-free survival.
Michael Tetzlaff, Vivian T Yin
exaly   +4 more sources

Eyelid Neoplasms [PDF]

open access: yes, 2002
Annajane B. Marlar
exaly   +3 more sources
Some of the next articles are maybe not open access.

Related searches:

Blepharitis and Neoplasms of the Canine Eyelid Margin and Skin

Veterinary Clinics of North America - Small Animal Practice, 2023
Canine eyelid masses (tumors) should include the differential clinical diagnoses of neoplasia and blepharitis. They have many common clinical signs including tumor, alopecia, and hyperemia. Biopsy and histologic examination remains the most effective diagnostic test to establish a confirmed diagnosis and appropriate treatment.
Bruce Grahn
exaly   +3 more sources

Eyelid Neoplasms of Dogs

American Journal of Veterinary Research, 1975
SUMMARY A survey of 202 canine eyelid neoplasms was conducted to identify the prevalence of tumor types and their biological behavior. Sebaceous gland tumors, melanomas, and papillomas made up 82.1% on neoplasms studied. Sebaceous tumors were most frequently encountered, comprising 44% of canine eyelid tumors.
J D, Krehbiel, R F, Langham
exaly   +3 more sources

Eyelid and Conjunctival Neoplasms [PDF]

open access: yes, 2011
The spectrum of neoplasms that can affect the eyelids and conjunctiva is vast. In this chapter, we review the epidemiology, clinical features, pathology, and management of these lesions. Basal cell carcinoma is the most common eyelid malignancy. Excision is the mainstay of treatment for this tumor that rarely metastasizes.
Lilly Droll, Aaron Savar, Bita Esmaeli
core   +4 more sources

Management of Eyelid Neoplasms in the Dog and Cat

Topics in Companion Animal Medicine, 2007
Eyelid neoplasms are common in the older dog and typically benign. Eyelid neoplasms in the cat are less common and more often malignant. Resection of eyelid masses may be curative; however, restoration of the eyelid structure after mass excision is essential for maintaining long-term ocular surface health.
exaly   +3 more sources

Excision of Neoplasms of the Bovine Lower Eyelid by H‐Blepharoplasty

Veterinary Surgery, 1991
Neoplasms of the lower eyelid in 14 cattle were treated by wide surgical excision and H‐blepharoplasty. Healing was by first intention, and cosmetic results were satisfactory in all cases. Lid function was satisfactory in 12 cattle, and there was no evidence of recurrence after at least 6 months in 12 cattle.
D M Rings, B L Hull
exaly   +3 more sources

Epigard in the Management of Eyelid Neoplasms [PDF]

open access: yesOphthalmic Surgery, Lasers and Imaging Retina, 1981
SUMMARY Definitive repair of a surgical wound of the anterior lamella of an eyelid should be delayed in some cases until the surgeon is sure of the histopathologic diagnosis of the lesion and the adequacy of his resection. Epigard is a polyurethane-polypropylene barrier dressing that can be sutured to wound edges, protecting underlying ...
Francis G La Piana
openaire   +3 more sources

Eyelid Neoplasms in the Beijing Tongren Eye Centre Between 1997 and 2006

Ophthalmic Surgery Lasers and Imaging Retina, 2008
Background and Objective: To examine the spectrum of eyelid neoplastic specimens obtained at the Beijing Tongren Eye Centre between 1997 and 2006. Patients and Methods: A total of 2,639 eyelid neoplasms were included in the study. Results:
Jost Jonas
exaly   +3 more sources

Multiple Eyelid Neoplasms in Cowden Syndrome [PDF]

open access: yesOphthalmic Plastic & Reconstructive Surgery, 2020
Adam R, Sweeney, Debra J, Shetlar
openaire   +3 more sources

Home - About - Disclaimer - Privacy